IL10 and rheumatoid arthritis: Stella et al. first studied the role of BMSC-EVs in RA models and confirmed their sufficient efficacy in alleviating experimental RA by inhibiting T and B lymphocyte proliferation, as well as by inducing Treg and IL-10-expressing regulatory B cells in a dose-dependent manner.